35092 Federal Register / Vol. 86, No. 124 / Thursday, July 1, 2021 / Notices 

data and potential policy or rule 

changes as tightly and as explicitly as 

possible. Where possible, we also 

encourage commenters to quantify and 

explain the benefits or costs associated 

with any policy or rule they discuss or, 

in the alternative, to explain the 

difficulties faced in trying to quantify 

benefits and costs in this context and 

how the Commission might nonetheless 

evaluate them in the absence of 

extensive or conclusive objective 

metrics. Moreover, in addition to 

identifying, analyzing, and submitting 

existing materials, we welcome 

commenters to take this opportunity to 

compile data or conduct further 

research that can be submitted to the 

Commission during the new comment 

window. 

13. Finally, we seek comment on 

whether there are any other legal or 

economic factors, changes, or issues that 

the Commission should consider in the 

context of this quadrennial review and, 

if so, how the Commission should 

evaluate or address them. 

14. Initial Regulatory Flexibility 

Analysis. The NPRM included an Initial 

Regulatory Flexibility Analysis (IRFA) 

pursuant to 5 U.S.C. 603, exploring the 

potential impact on small entities of the 

Commission’s proposals. We invite 

parties to file comments on the IRFA in 

light of this request to refresh the 

record. 

15. Ex Parte Rules—Permit But 

Disclose. This proceeding shall be 

treated as a ‘‘permit-but-disclose’’ 

proceeding in accordance with the 

Commission’s ex parte rules (47 CFR 

1.1200 et seq.). Persons making ex parte 

presentations must file a copy of any 

written presentation or a memorandum 

summarizing any oral presentation 

within two business days after the 

presentation (unless a different deadline 

applicable to the Sunshine period 

applies). Persons making oral ex parte 

presentations are reminded that 

memoranda summarizing the 

presentation must (1) list all persons 

attending or otherwise participating in 

the meeting at which the ex parte 

presentation was made, and (2) 

summarize all data presented and 

arguments made during the 

presentation. If the presentation 

consisted in whole or in part of the 

presentation of data or arguments 

already reflected in the presenter’s 

written comments, memoranda or other 

filings in the proceeding, the presenter 

may provide citations to such data or 

arguments in his or her prior comments, 

memoranda, or other filings (specifying 

the relevant page and/or paragraph 

numbers where such data or arguments 

can be found) in lieu of summarizing 

them in the memorandum. Documents 

shown or given to Commission staff 

during ex parte meetings are deemed to 

be written ex parte presentations and 

must be filed consistent with rule 

1.1206(b). In proceedings governed by 

rule 1.49(f) or for which the 

Commission has made available a 

method of electronic filing, written ex 

parte presentations and memoranda 

summarizing oral ex parte 

presentations, and all attachments 

thereto, must be filed through the 

electronic comment filing system 

available for that proceeding, and must 

be filed in their native format (e.g., .doc, 

.xml, .ppt, searchable .pdf). Participants 

in this proceeding should familiarize 

themselves with the Commission’s ex 

parte rules. 

16. Filing Comments and Replies. All 

filings must be submitted in MB Docket 

No. 18–349. Pursuant to sections 1.415 

and 1.419 of the Commission’s rules, 47 

CFR 1.415, 1.419, interested parties may 

file comments and reply comments on 

or before the dates indicated on the first 

page of this document. Comments may 

be filed using the Commission’s 

Electronic Comment Filing System 

(ECFS). See Electronic Filing of 

Documents in Rulemaking Proceedings, 

63 FR 24121 (1998). 

• Electronic Filers: Comments may be 

filed electronically using the internet by 

accessing the ECFS: http://apps.fcc.gov/ 

ecfs/. 

• Paper Filers: Parties who choose to 

file by paper must file an original and 

one copy of each filing. 

• Filings can be sent by commercial 

overnight courier, or by first-class or 

overnight U.S. Postal Service mail. All 

filings must be addressed to the 

Commission’s Secretary, Office of the 

Secretary, Federal Communications 

Commission. 

• Commercial overnight mail (other 

than U.S. Postal Service Express Mail 

and Priority Mail) must be sent to 9050 

Junction Drive, Annapolis Junction, MD 

20701. U.S. Postal Service first-class, 

Express, and Priority mail must be 

addressed to 45 L Street NE, 

Washington, DC 20554. 

• Effective March 19, 2020, and until 

further notice, the Commission no 

longer accepts any hand or messenger 

delivered filings. This is a temporary 

measure taken to help protect the health 

and safety of individuals, and to 

mitigate the transmission of COVID–19. 

See FCC Announces Closure of FCC 

Headquarters Open Window and 

Change in Hand-Delivery Policy, Public 

Notice, DA 20–304 (March 19, 2020). 

https://www.fcc.gov/document/fcccloses-headquarters-open-window-andchanges-hand-delivery-policy. 

17. People with Disabilities. To 

request materials in accessible formats 

for people with disabilities (braille, 

large print, electronic files, audio 

format), send an email to fcc504@fcc.gov 

or call the Consumer & Governmental 

Affairs Bureau at 202–418–0530 (voice), 

202–418–0432 (TTY). 

18. Additional Information. For 

additional information on this 

proceeding, please contact Ty Bream of 

the Media Bureau, Industry Analysis 

Division, Ty.Bream@fcc.gov, (202) 418– 

0644. 

Federal Communications Commission. 

Thomas Horan, 

Chief of Staff, Media Bureau. 

[FR Doc. 2021–14079 Filed 6–30–21; 8:45 am] 

BILLING CODE 6712–01–P 

FEDERAL ELECTION COMMISSION 

Sunshine Act Meeting 

TIME AND DATE: Tuesday, July 13, 2021 

at 10:00 a.m. and its continuation at the 

conclusion of the open meeting on July 

15, 2021. 

PLACE: 1050 First Street NE, 

Washington, DC (this meeting will be a 

virtual meeting). 

STATUS: This meeting will be closed to 

the public. 

MATTERS TO BE CONSIDERED: Compliance 

matters pursuant to 52 U.S.C. 30109. 

Matters concerning participation in 

civil actions or proceedings or 

arbitration. 

* * * * * 

CONTACT PERSON FOR MORE INFORMATION: 

Judith Ingram, Press Officer. Telephone: 

(202) 694–1220. 

Vicktoria J. Allen, 

Acting Deputy Secretary of the Commission. 

[FR Doc. 2021–14237 Filed 6–29–21; 4:15 pm] 

BILLING CODE 6715–01–P 

FEDERAL RESERVE SYSTEM 

Change in Bank Control Notices; 

Acquisitions of Shares of a Bank or 

Bank Holding Company 

The notificants listed below have 

applied under the Change in Bank 

Control Act (Act) (12 U.S.C. 1817(j)) and 

§ 225.41 of the Board’s Regulation Y (12 

CFR 225.41) to acquire shares of a bank 

or bank holding company. The factors 

that are considered in acting on the 

applications are set forth in paragraph 7 

of the Act (12 U.S.C. 1817(j)(7)). 

The public portions of the 

applications listed below, as well as 

other related filings required by the 


khammond on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 86, No. 124 / Thursday, July 1, 2021 / Notices 35093 

Board, if any, are available for 

immediate inspection at the Federal 

Reserve Bank(s) indicated below and at 

the offices of the Board of Governors. 

This information may also be obtained 

on an expedited basis, upon request, by 

contacting the appropriate Federal 

Reserve Bank and from the Board’s 

Freedom of Information Office at 

https://www.federalreserve.gov/foia/ 

request.htm. Interested persons may 

express their views in writing on the 

standards enumerated in paragraph 7 of 

the Act. 

Comments regarding each of these 

applications must be received at the 

Reserve Bank indicated or the offices of 

the Board of Governors, Ann E. 

Misback, Secretary of the Board, 20th 

Street and Constitution Avenue NW, 

Washington, DC 20551–0001, not later 

than July 16, 2021. 

A. Federal Reserve Bank of St. Louis 

(Holly A. Rieser, Manager) P.O. Box 442, 

St. Louis, Missouri 63166–2034. 

Comments can also be sent 

electronically to 

Comments.applications@stls.frb.org: 

1. Steuart L. Walton, Thomas L. 

Walton, Alice A. Proietti, and James M. 

Walton, all of Bentonville, Arkansas; to 

become members of the Walton Family 

Group, a group acting in concert to 

retain voting shares of Arvest Bank 

Group, Inc., Bentonville, Arkansas, and 

thereby indirectly retain voting shares of 

Arvest Bank, Fayetteville, Arkansas. 

Board of Governors of the Federal Reserve 

System, June 28, 2021. 

Michele Taylor Fennell, 

Deputy Associate Secretary of the Board. 

[FR Doc. 2021–14126 Filed 6–30–21; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Healthcare Research and 

Quality 

Meeting of the National Advisory 

Council for Healthcare Research and 

Quality 

AGENCY: Agency for Healthcare Research 

and Quality (AHRQ), HHS. 

ACTION: Notice of public meeting. 

SUMMARY: This notice announces a 

meeting of the National Advisory 

Council for Healthcare Research and 

Quality. 

DATES: The meeting will be held on 

Wednesday, July 14, 2021, from 10:00 

a.m. to 2:30 p.m. 

ADDRESSES: The meeting will be held 

virtually. 

FOR FURTHER INFORMATION CONTACT: 

Jaime Zimmerman, Designated 

Management Official, at the Agency for 

Healthcare Research and Quality, 5600 

Fishers Lane, Mail Stop 06E37A, 

Rockville, Maryland 20857, (301) 427– 

1456. For press-related information, 

please contact Bruce Seeman at (301) 

427–1998 or Bruce.Seeman@

AHRQ.hhs.gov. 

Closed captioning will be provided 

during the meeting. If another 

reasonable accommodation for a 

disability is needed, please contact the 

Food and Drug Administration (FDA) 

Office of Equal Employment 

Opportunity and Diversity Management 

on (301) 827–4840, no later than Friday, 

July 2, 2021. The agenda, roster, and 

minutes will be available from Ms. 

Heather Phelps, Committee 

Management Officer, Agency for 

Healthcare Research and Quality, 5600 

Fishers Lane, Rockville, Maryland 

20857. Ms. Phelps’ phone number is 

(301) 427–1128. 

SUPPLEMENTARY INFORMATION: 

I. Purpose 

In accordance with section 10(a) of 

the Federal Advisory Committee Act, 5 

U.S.C. App., this notice announces a 

meeting of the National Advisory 

Council for Healthcare Research and 

Quality (the Council). The Council is 

authorized by Section 941 of the Public 

Health Service Act, 42 U.S.C. 299c. In 

accordance with its statutory mandate, 

the Council is to advise the Secretary of 

the Department of Health and Human 

Services and the Director of AHRQ on 

matters related to AHRQ’s conduct of its 

mission including providing guidance 

on (A) priorities for health care research, 

(B) the field of health care research 

including training needs and 

information dissemination on health 

care quality and (C) the role of the 

Agency in light of private sector activity 

and opportunities for public private 

partnerships. The Council is composed 

of members of the public, appointed by 

the Secretary, and Federal ex-officio 

members specified in the authorizing 

legislation. 

II. Agenda 

On Wednesday, July 14, 2021, the 

Council meeting will convene at 10:00 

a.m., with the call to order by the 

Council Chair and approval of previous 

Council summary notes. The meeting 

will begin with an update on AHRQ’s 

recent accomplishments in Health 

Systems Research, Practice 

Improvement, and Data and Analytics. 

The agenda will also include 

discussions on Strategic Opportunities 

for FY22, Opportunities to Advance 

Telehealth and Advancing Patient 

Safety. The meeting will adjourn at 2:30 

p.m. The meeting is open to the public. 

For information regarding how to access 

the meeting as well as other meeting 

details, including information on how to 

make a public comment, please go to 

https://www.ahrq.gov/news/events/nac/. 

The final agenda will be available on the 

AHRQ website no later than 

Wednesday, July 7, 2021. 

Dated: June 25, 2021. 

Marquita Cullom, 

Associate Director. 

[FR Doc. 2021–14010 Filed 6–30–21; 8:45 am] 

BILLING CODE 4160–90–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[Docket No. CDC–2021–0060] 

Advisory Committee on Immunization 

Practices (ACIP); Cancellation of 

Meeting 

Notice is hereby given of a change in 

the meeting of the Advisory Committee 

on Immunization Practices (ACIP); June 

18, 2021, 11:00 a.m. to 5:00 p.m., EDT 

(dates and times subject to change), in 

the original FRN. 

The virtual meeting was published in 

the Federal Register on June 15, 2021, 

Volume 86, Number 113, pages 31716– 

31717. 

Due to the Federal holiday on June 18, 

2021, the ACIP meeting has been 

canceled in its entirety. In addition, the 

previously scheduled June 18, 2021 

agenda items will be discussed at the 

ACIP meeting on June 23–25, 2021. 

Additionally, public comments 

submitted to docket number CDC–2021– 

0060 will be shared with ACIP members 

at or prior to the June 23–25, 2021 

meeting. 

FOR FURTHER INFORMATION CONTACT: 

Stephanie Thomas, ACIP Committee 

Management Specialist, Centers for 

Disease Control and Prevention, 

National Center for Immunization and 

Respiratory Diseases, 1600 Clifton Road 

NE, MS–H24–8, Atlanta, Georgia 30329– 

4027; Telephone: (404) 639–8367; 

Email: ACIP@cdc.gov. 

The Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 


khammond on DSKJM1Z7X2PROD with NOTICES